A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 1, 1998, Pages 29-35

  Lawrence, Julia A ^a,d   Merino, Maria J ^a   Simpson, Jean F ^b,c   Manrow, Richard E ^a   Page, David L ^c   Steeg, Patricia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RETINOID X RECEPTOR;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CARCINOMA IN SITU; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RISK; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0031908095     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. van de Vijer, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O , and Nusse, R Neu-protein overexpression in breast cancer. N. Engl J Med , 319: 1239-1245, 1988.
2. Zafrani, B , Leroyer, A , Fourquet, A., Laurent, M., Trophilme, D., Validire, P , and Sastre-Garau, X. Mammographically detected ductal carcinoma in situ of the breast with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity Semin. Diagn Pathol , 11: 208-214, 1994.
3. Weinstat-Saslow, D., Merino, M. J , Manrow, R. E Lawrence, J. A., Bluth, R F., Wittenbel, K. D., Simpson, J F., Page, D. L., and Steeg, P. S Overexpression of cychn D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions Nat Med , 1: 1257-1260, 1995.
4. Walker, R. A., and Dearing, S. J Transforming growth factor β 1 in ductal carcinoma in situ and invasive carcinoma of the breast. Eur. J. Cancer. 28: 641-644, 1992.
5. Tsuda, H., Fukutomi, T., and Hirohashi, S. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade Clin. Cancer Res., 1: 261-267, 1995
6. Steeg, P. S , Clare, S. E , Lawrence, J A , and Zhou, Q. Molecular analysis of premalignant and carcinoma in situ lesions of the human breast Am J. Pathol. 149: 733-738, 1996.
7. Schmitt, F C., Leal, C., and Lopes, C. p53 protein expression and nuclear DNA content in breast intraductal proliferations. J Pathol., 176: 233-241, 1995
8. Poller, D., Roberts, E., Bell, J., Elston, C., Blarney, R , and Ellis, I. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erb-B-2 protein. Hum. Pathol., 24: 463-468, 1993.
9. Poller, D. N., Snead, D. R. J , Roberts, E. C., Galea, M., Bell, J A., Gilmour, A., Elston, C. W., Blarney, R W., and Ellis, I. O. Oestrogen receptor expression in ductal carcinoma m situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. Br. J. Cancer, 68: 156-161, 1993
10. O'Malley, F , Vnencak-Jones, C., DuPont, W , Parl, F., Manning, S , and Page, D p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast: immunohistochemical and sequencing data Lab Invest., 71: 67-72, 1994.
11. Lodato, R., Maguire, H., Greene, M., Weiner, D., and LiVolsi, V. Immunohistochemical evaluation of c-erb-B-2 oncogene expression m ductal carcinoma in situ and atypical ductal hyperplasia of the breast Mod. Pathol., 3: 449-454, 1990.
12. Leal, C. B., Schmitt, F. C., Bento, M. J., Maia, N. C., and Lopes, C. S. Ductal carcinoma in situ of the breast: histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2. Cancer (Phila), 75: 2123-2131, 1994
13. Giri, D., Dundas, S , Nottingham, J., and Underwood, J. Oestrogen receptors in benign epithelial lesions and intraductal carcinomas of the breast an immunohistological study. Histopathology, 15: 575-584, 1989.
14. Evans, A. J., Pinder, S E., Ellis, I. O., Sibbering, D. M., Elston, C. W., Poller, D. N., and Wilson, A. R. M. Correlations between mammographic features of ductal carcinoma in situ (DCIS) and c-erb-B2 oncogene expression. Clin. Radiol., 49: 559-562, 1994.
15. Bur, M., Zimarowski, M., Schnitt, S., Baker, S., and Lew, R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer (Phila.), 69: 1174-1181, 1992.
16. Allred, D. C , Clark, G M., Molina, R. A., Tandon, K., Schnitt, S. J., Gilchrist, K. W., Osborne, C. K., Tormey, D. C., and McGuire, W. L. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of m situ to invasive breast cancer. Hum Pathol , 23 974-979, 1992.
17. Aasmundstad, T. A., and Haugen, O. A. DNA ploidy in intraductal breast carcinomas Eur. J. Cancer, 26: 956-959, 1990.
18. DuPont, W , and Page, D. Risk factors for breast cancer in women with proliferative breast disease. N Engl. J. Med , 312: 146-151, 1985.
19. Page, D Cancer risk assessment in benign breast biopsies. Hum Pathol., 17: 871-874, 1986
20. Otteson, G. L , Graversen, H. P., Blichert, T. M , Zedeler, K., and Andersen, J. A Ductal carcinoma in situ of the female breast: short term results of a prospective nationwide study Am J. Surg. Pathol., 16: 1183-1196, 1992
21. Ward, B. A., McKhann, C F., and Ravikkumar, T. S. Ten year follow-up of breast carcinoma in situ in Connecticut. Arch Surg. 127 1392-1395, 1992.
22. Bartkova, J., Lukas, J , Muller, H , Lutzhoft, D., Strauss. M , and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994.
23. Buckley, M., Sweeney, K., Hamilton, J., Sini, R., Manning, D., Nicholson, R., deFazio, A., Watts, C., Musgrove, E , and Sutherland, D. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
24. Dickson, C., Fantl, V , Gillett, C , Brookes, S., Bartek, J , Smith, R , Fisher, C., Barnes, D., and Peters, G. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer Cancer Lett., 90: 43-50, 1995
25. Gillett, C., Fantl, V , Smith, R., Fisher, C , Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994
26. Gillet, C , Smith, P , Gregory, W., Richards, M., Millis, R., Peters, G., and Barnes, D Cyclin D1 and prognosis in human breast cancer. Int. J Cancer, 69: 92-99, 1996.
27. Courjal, F., Louason, G., Speiser, P , Katasaros, D., Zeillinger, R , and Theillet, C Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors Int J. Cancer, 69: 247-253, 1996
28. Keyomarsi, K., and Pardee, A. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90: 1112-1116, 1993.
29. Michalides, R, Hageman, P., van Tinteren, H., Houben, L , Wientjens, E., Klopmaker, R., and Peterse, J. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer, 73 728-734, 1996.
30. Peters, G., Fantl, V., Smith, R., Brookes, S., and Dickson, C. Chromosome 11q13 markers and D-type cyclins in breast cancer Breast Cancer Res. Treat , 33: 125-135, 1995.
31. Zhang, S-Y., Caamano, J., Cooper, F., Guo, X., and Klein-Szanto, A. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol, 102: 695-698, 1994.
32. Zuckerberg, L., Yang, W., Gadd, M., Thor, A , Koerner, F., Schmidt, E., and Arnold, A. Cyclin D1 (PRAD1) protein expression m breast cancer, approximately one third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol., 8: 560-567, 1995.
33. Wang, T. C., Cardiff, R. D , Zuckerberg, L , Lees, E., Arnold, A , and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
34. 1 to complete the cell cycle Proc Natl Acad. Sci USA. 91: 8022-8026, 1994.
35. Amos, B , and Lotan, R Retinoid sensitive cells and cell lines. Methods Enzymol., 190: 217-225, 1990
36. Clifford, J. L., Petkovich, M , Chambon, P., and Lotan, R. Induction by β-all-trans retinoic acid of nuclear retinoic acid receptor β (RARβ) in urine melanoma cells. Mol. Endocrinol., 4: 1546-1555, 1989.
37. Lotan, R. Retinoids as modulators of tumor cell invasion and metastasis Semin. Cancer Biol., 2: 197-208, 1991.
38. Lotan, R., Hendrix, M, J. C., and Lippman, S. M. Retinoids in the Management of Melanoma Oxford. United Kingdom: Blackwell Scientific Publications, Ltd., 1991.
39. McCue, P A., Thomas, R S , Schroeder, D., Gubler, M., and Sherman, M. I. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines. Cancer Res., 48: 3772-3779, 1988.
40. Sherman, M. I. Retinoids and Cell Differentiation. Boca Raton, FL: CRC Press, Inc., 1986.
41. Speers, W. C., and Altmann, M. Chemically induced differentiation of murine embryonal carcinomas in vivo: transplantation of differentiated tumors. Cancer Res., 44: 2129-2135, 1984.
42. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses Semin Cell Biol., 5: 115-125, 1994.
43. Mangelsdorf, D J., and Evans, R. M. The RXR heterodimers and orphan receptors Cell, 83: 841-850, 1995.
44. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J-Y., Staub, A , Garnier, J-M , Mader, S., and Chambon, P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell, 68: 377-395, 1992.
45. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.), 345: 224-229, 1990
46. Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A , Zhou, J. Y., Ong, E. S., Oro, A E., Kakizuka, A., and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cic-retinoic acid. Genes Dev., 6: 329-344, 1992
47. Schnitt, F. C., Leal, C., and Lopes. C p53 protein expression and nuclear DNA content in breast intraductal proliferations. J. Pathol., 176: 233-241, 1995
48. Zwijsen, R. M L., Wientjens, E., Klompmaker, R., van der Smam, J., Bernards, R , and Michalides, R. J. CDK-independent activation of estrogen receptor by cyclin D1 Cell, 88: 405-415, 1997.
49. O'Brien, M. L., Rangwala, S. M , Henry, K. W., Weinberger, C , Crick, D. C , Waechter, C. J , Feller, D R., and Noonan, D. J. Convergence of three steroid receptor pathways in the mediation of non-genotoxic hepatocarcinogenesis Carcinogenesis (Lond.), 17: 185-190, 1996.
50. Leid, M., Kastner, P., and Chambon, P. Multiplicity generates diversity in retinoic acid signaling pathways. Trends Biochem. Sci. 17: 427-433, 1992.
51. Heyman, R. A. Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R M., and Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor Cell, 68 397-406, 1992.
52. Levin, A. A , Sturzenbecker, L. J., Kazmer, S , Bosakowski, T., Huselton, C., Allenby, G , Speck, K., Kratzeisen, C., Rosenbergwe, M., Lovey, A , and Grippo, J. F 9-cis-retinoic acid stereoisomer binds and activates nuclear receptor RXRα. Nature (Lond.), 355: 359-361, 1992
53. Bugge, T. H., Pohl, J., Lonnoy, O., and Stunnenberg, H G RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors EMBO J. 11: 1409-1418, 1992.
54. Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., and Evans, R M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature (Lond.), 358: 446-449, 1992.
55. Kliewer, S. A., Umesono, K., Noonan, D J., Heyman, R A , and Evans, R. M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature (Lond.), 358: 771-774, 1992.
56. Marks, M. S., Hallenback, P. L., Nagata, T., Segars, J. H., Apella, E , Nikodem, V. M., and Ozato, K H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes EMBO J , 11: 1419-1435, 1992.
57. Yu, V. C., Delsert, C., Anderson, B., Holloway, J M., Devary, O. V., Daar, A. M., Kim, S. Y , Bouun, J-M., Glass, C. K., and Rosenfeld, M. G RXRb: a co-regulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements Cell, 67: 1251-1266, 1991.
58. Zhang, X., Hoffman, B., Tran, P. B-V., Graupner, G , and Pfahl, M Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (Lond.), 355: 441-446, 1992.
59. Schrader, M., Wyss, A., Sturzenbecker, L. J., Grippo, J. F., LeMotte, P., and Carlberg, C. RXR-dependent and RXR-independent transactivation by retinoic acid receptors Nucl. Acids Res., 21: 1231-1237, 1993
60. Zhang, X-K., Lehmann, J , Hoffmann, B., Dawson, M. I., Cameron, J., Graupner, G , Hermann, T , Tran, P., and Pfahl, M. Homodimer formation of retinoid X receptor induced by 9-cis-retinoic acid Nature (Lond.), 358: 587-591, 1992.
61. Mangelsdorf, D J., Umesono, K., Kliewer, S A , Borgmeyer, U., Ong, E S., and Evans, R M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell, 66: 555-561, 1991.
62. Rottman, J. N., Widom, R. L., Nadal-Ginard, B., Mahdavi, V , and Karathanasis, S. K. A retinoic acid-responsive element in the apolipoprotein A1 gene distinguishes between two different retinoic acid response pathways. Mol. Cell. Biol., 11 3814-3820, 1991.
63. Allegretto, E. A., Shevde, N , Zou, A., Howell, S. R , Boehm, M. F., Hollis, B. W., and Pike, J W Retinoid X receptor acts as a hormone receptor in vivo to induce a key metabolic enzyme for 1,25-dihydroxyvitamin D3. J. Biol. Chem., 270: 23906-23909, 1995.
64. Davis, K D , Berrodin, T. J., Stelmach, J E , Winkler, J. D., and Lazar, M. A. Endogenous retinoid X receptors can function as hormone receptors in pituitary cells. Mol Cell. Biol., 14 7105-7110, 1994.
65. Wan, Y-J. Y., Wang, L., and Wu, T-C J. Dexamethasone increases the expression of retinoid X receptor genes in rat hepatoma cell lines. Lab. Invest , 70: 547-552, 1994.
66. Wan, Y-J. Y., Wang, L , and Wu, T-C. J The expression of retinoid X receptor genes is regulated by all-trans- and 9-cis-retinoic acid in F9 teratocarcinoma cells. Exp. Cell Res., 210: 55-61, 1994.
67. van de Leede, B M., van de Brink, C. E , and van de Saag, P. T. Retinoic acid receptor and retinoid X receptor expression in retinoic acid resistant human tumor cell lines. Mol. Carcinog., 8: 112-122, 1993
68. Zhao, Z. M., Sheikh, M. S., Rishi, A K , Dawsun, M. I., Li, X S , Wilber, J. F., Feng, P., and Fontana, J. A Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Exp Cell Res, 219: 555-561, 1995.
69. Segars, J H., Marks, M. S , Hirschfeld, S., Driggers, P. H., Martinez, E., Grippo, J. F., Wahli, W. and Ozato, K. Inhibition of estrogen-responsive gene activation by the retinoid X receptor, evidence for multiple inhibitory pathways. Mol. Cell. Biol., 13: 2258-2268, 1993
70. Shao, Z-M, Sheikh, M. S., Rishi, A K., Dawson, M. I , Li, X-S., Wilber, J. F., Feng, P., and Fontana, J A. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp. Cell Res., 218: 1-8, 1995.
71. Gottardis, M. M , Bischoff, E. D., Shirley, M. A., Wagoner, M. A., Lamph, W. W., and Heyman, R. A Chemoprevention of mammary carcinoma by LGD 1069 (Targretin): Aa RXR-selective ligand. Cancer Res., 56: 5566-5570, 1996.
72. Gottardis, M. M , Lamph, W. W., Shalinsky, D. R., Wellstein, A , and Heyman, R. A. The efficacy of 9-cis-retinoic acid in experimental models of breast cancer. Breast Cancer Res. Treat., 38: 85-96, 1996.
73. Darwiche, N., Celli, G, Tennenbaum, T., Glick, A. B., Yuspa, S. H., and Luca, L. M. D. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res., 55: 2774-2782, 1995.
74. Spanjaard, R. A., Sugawara, A., Ikeda, M., and Chin, W. W Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor β gene in S91 melanoma cells. J. Biol Chem., 270: 17429-17436, 1995